JNJ vs. ISRG, MRNA, NVAX, ABBV, BRK.B, LLY, MRK, PFE, PG, and XOM
Should you be buying Johnson & Johnson stock or one of its competitors? The main competitors of Johnson & Johnson include Intuitive Surgical (ISRG), Moderna (MRNA), Novavax (NVAX), AbbVie (ABBV), Berkshire Hathaway (BRK.B), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), Pfizer (PFE), Procter & Gamble (PG), and Exxon Mobil (XOM).
Johnson & Johnson vs. Its Competitors
Johnson & Johnson (NYSE:JNJ) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.
In the previous week, Johnson & Johnson had 49 more articles in the media than Intuitive Surgical. MarketBeat recorded 112 mentions for Johnson & Johnson and 63 mentions for Intuitive Surgical. Johnson & Johnson's average media sentiment score of 1.34 beat Intuitive Surgical's score of 1.02 indicating that Johnson & Johnson is being referred to more favorably in the media.
Johnson & Johnson currently has a consensus target price of $188.88, indicating a potential upside of 0.20%. Intuitive Surgical has a consensus target price of $594.19, indicating a potential upside of 31.36%. Given Intuitive Surgical's higher possible upside, analysts clearly believe Intuitive Surgical is more favorable than Johnson & Johnson.
Johnson & Johnson has higher revenue and earnings than Intuitive Surgical. Johnson & Johnson is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Intuitive Surgical has a net margin of 28.51% compared to Johnson & Johnson's net margin of 25.00%. Johnson & Johnson's return on equity of 32.49% beat Intuitive Surgical's return on equity.
Johnson & Johnson has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500.
69.6% of Johnson & Johnson shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 0.2% of Johnson & Johnson shares are owned by insiders. Comparatively, 0.7% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Johnson & Johnson beats Intuitive Surgical on 9 of the 17 factors compared between the two stocks.
Get Johnson & Johnson News Delivered to You Automatically
Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding JNJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Johnson & Johnson Competitors List
Related Companies and Tools
This page (NYSE:JNJ) was last updated on 10/5/2025 by MarketBeat.com Staff